A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Childhood Absence Epilepsy Clinical Trial

Official title:
A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF BRIVARACETAM IN STUDY PARTICIPANTS WITH CHILDHOOD ABSENCE EPILEPSY OR JUVENILE ABSENCE EPILEPSY

Status Not yet recruiting

Clinical Trial Summary

The purpose of the study is to investigate the long-term safety and tolerability of brivaracetam in study participants with childhood absence epilepsy or juvenile absence epilepsy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06315322
Study type	Interventional
Source	UCB Pharma
Contact	UCB Cares
Phone	1-844-599-2273 (USA)
Email	ucbcares@ucb.com
Status	Not yet recruiting
Phase	Phase 3
Start date	June 14, 2024
Completion date	February 28, 2029

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00393666` - Why Are Patients With Absence Seizures Absent? A Brain Imaging Study	N/A
Terminated	`NCT06153186` - Flunarizine for Treatment Resistant Absence Epilepsy	Phase 2
Enrolling by invitation	`NCT05109234` - A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy	Phase 3
Recruiting	`NCT04666610` - A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy	Phase 3
Completed	`NCT00088452` - Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study	Phase 3
Terminated	`NCT03355300` - Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures	Phase 2
Terminated	`NCT03336242` - Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures	Phase 2
Completed	`NCT00361010` - A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy	N/A
Completed	`NCT00041951` - Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study	N/A
Recruiting	`NCT06310772` - Assessing Comorbidities in Epilepsy Using Eye Movement Recordings